| APREPITANT |
211835 |
001 |
ANDA |
APREPITANT |
CAPSULE;ORAL |
40MG |
No
|
No
|
2020/10/21
|
2020/10/21
|
TORRENT |
Prescription |
| APREPITANT |
211835 |
002 |
ANDA |
APREPITANT |
CAPSULE;ORAL |
80MG |
No
|
No
|
2020/10/21
|
2020/10/21
|
TORRENT |
Prescription |
| APREPITANT |
211835 |
003 |
ANDA |
APREPITANT |
CAPSULE;ORAL |
125MG |
No
|
No
|
2020/10/21
|
2020/10/21
|
TORRENT |
Prescription |
| FOSAPREPITANT DIMEGLUMINE |
203939 |
001 |
ANDA |
FOSAPREPITANT DIMEGLUMINE |
POWDER;INTRAVENOUS |
EQ 150MG BASE/VIAL |
No
|
No
|
2020/12/08
|
2020/12/08
|
SANDOZ |
Discontinued |
| FOSAPREPITANT DIMEGLUMINE |
211160 |
001 |
ANDA |
FOSAPREPITANT DIMEGLUMINE |
POWDER;INTRAVENOUS |
EQ 150MG BASE/VIAL |
No
|
No
|
2020/12/09
|
2020/12/09
|
DR REDDYS |
Prescription |
| FOSAPREPITANT DIMEGLUMINE |
210625 |
001 |
ANDA |
FOSAPREPITANT DIMEGLUMINE |
POWDER;INTRAVENOUS |
EQ 150MG BASE/VIAL |
No
|
No
|
2021/01/12
|
2021/01/12
|
EUGIA PHARMA |
Prescription |
| FOSAPREPITANT DIMEGLUMINE |
212143 |
001 |
ANDA |
FOSAPREPITANT DIMEGLUMINE |
POWDER;INTRAVENOUS |
EQ 150MG BASE/VIAL |
No
|
No
|
2021/03/03
|
2021/03/03
|
CHIA TAI TIANQING |
Prescription |
| FOSAPREPITANT DIMEGLUMINE |
214616 |
001 |
ANDA |
FOSAPREPITANT DIMEGLUMINE |
POWDER;INTRAVENOUS |
EQ 150MG BASE/VIAL |
No
|
No
|
2021/07/29
|
2021/07/29
|
ASPIRO |
Prescription |
| FOSAPREPITANT DIMEGLUMINE |
213199 |
001 |
ANDA |
FOSAPREPITANT DIMEGLUMINE |
POWDER;INTRAVENOUS |
EQ 150MG BASE/VIAL |
No
|
No
|
2021/10/04
|
2021/10/04
|
ARTHUR GRP |
Discontinued |
| FOSAPREPITANT DIMEGLUMINE |
214683 |
001 |
ANDA |
FOSAPREPITANT DIMEGLUMINE |
POWDER;INTRAVENOUS |
EQ 150MG BASE/VIAL |
No
|
No
|
2023/05/16
|
2023/05/16
|
PIRAMAL CRITICAL |
Prescription |
| APREPITANT |
218754 |
001 |
NDA |
APREPITANT |
INJECTABLE;INTRAVENOUS |
130MG/18ML (7.2MG/ML) |
No
|
No
|
2024/07/25
(TA)
|
--
|
AZURITY |
None (Tentative Approval) |
| APREPITANT |
216976 |
001 |
ANDA |
APREPITANT |
INJECTION, EMULSION |
130MG/130ML |
No
|
No
|
2024/12/11
(TA)
|
--
|
MYLAN PHARMACEUTICALS INC |
Prescription |